Pfizer Inc.

NYSE:PFE  
51.62
+1.53 (+3.06%)
4:02:09 PM EDT: $51.46 -0.16 (-0.31%)
Products

Pfizer Granted FDA Fast Track Designation For Ervogastat/Clesacostat Combination For Treatment Of Non-Alcoholic Steatohepatitis

Published: 05/26/2022 11:05 GMT
Pfizer Inc. (PFE) - Pfizer Granted FDA Fast Track Designation for Ervogastat/clesacostat Combination for the Treatment of Non-alcoholic Steatohepatitis (nash).